The Pulmonary Alveolar Resonant Collapse Mine is a pressure-triggered area-denial device that detonates with a primary acoustic charge tuned to the resonant frequency of alveolar sac tissue in human lung parenchyma. Rather than generating a lethal overpressure blast, the PARCM-6 produces a precisely calibrated acoustic burst that propagates through the thoracic cavity and causes simultaneous alveolar collapse across both lung fields within the effective radius. The mine's casing is designed to channel the acoustic output in a toroidal pattern at approximately chest height, maximizing coupling with the respiratory system while minimizing ground-transmitted vibration that might trigger secondary devices.

Developed under a LAZARUS PHARMACEUTICALS research contract nominally studying respiratory disease progression modeling, the PARCM-6's core technology derived from acoustic stimulation arrays used to induce controlled alveolar stress in research subjects. The weaponized variant uses a neural feedback loop in its detonation sequencer to adapt the acoustic burst profile based on ambient sound environment, ensuring consistent resonant output regardless of background noise conditions. This adaptive sequencing was the critical engineering step that transformed a laboratory instrument into a deployable weapon.

In the field, the PARCM-6 is both feared and valued for its aftermath: targets are alive but incapacitated, unable to breathe effectively, requiring immediate medical intervention. This creates a secondary tactical effect — responders drawn to aid casualties enter the mine's area, and operators can set sequential PARCM-6s to detonate on the response pattern. Street medics have developed a grim protocol for 'white lung fields' — areas suspected of PARCM-6 deployment — that involves approach via specific corridors and immediate positive-pressure ventilation equipment.